A randomized clinical trial of delirium prevention

A randomized clinical trial of delirium prevention - A randomized clinical trial of delirium prevention

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016471

Enrollment

Registered

2015-03-01

Start date

2015-05-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

delirium

Interventions

Suvorexant 7days between 20 and 64 years of age :20mg 65 years ofage and older :15mg Conventional treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients newly admitted to emergency department

Exclusion criteria

Exclusion criteria: 1) Alcohol dependence, amphetamine abuse 2) under medication with psychoactive drug

Design outcomes

Primary

Measure	Time frame
Incidence of delirium	—

Secondary

Measure	Time frame
Discontinuation due to adverse phenomenon	—

Countries

Japan

Contacts

Public ContactKazunari Azuma

Tokyo Medical University Hospital emergency and critical care medicine

jpn4077@yahoo.co.jp03-3342-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026